Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer

BACKGROUND: Our aim is to study if mammographic density (MD) prior to neoadjuvant chemotherapy is a predictive factor in accomplishing a pathological complete response (pCR) in neoadjuvant-treated breast cancer patients. METHODS: Data on all neoadjuvant treated breast cancer patients in Southern Swe...

Descripción completa

Detalles Bibliográficos
Autores principales: Skarping, Ida, Förnvik, Daniel, Sartor, Hanna, Heide-Jørgensen, Uffe, Zackrisson, Sophia, Borgquist, Signe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937786/
https://www.ncbi.nlm.nih.gov/pubmed/31888552
http://dx.doi.org/10.1186/s12885-019-6485-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937786/
https://www.ncbi.nlm.nih.gov/pubmed/31888552
http://dx.doi.org/10.1186/s12885-019-6485-4

Ejemplares similares